Osteoporosis and fractures in postmenopausal women using estrogen

Archives of Internal Medicine

Volumn 162, Issue 20, 2002, Pages 2278-2284

  Nelson, Heidi D ^a,b   Rizzo, Joanne ^c   Harris, Emily ^c   Cauley, Jane ^d   Ensrud, Kristine ^e   Bauer, Douglas C ^f   Orwoll, Eric ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c KAISER PERMANENTE   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

AGED; ARTICLE; BONE DENSITY; CALCANEUS; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HIP; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; VERTEBRA FRACTURE; WORLD HEALTH ORGANIZATION; WRIST FRACTURE;

EID: 0037111793     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.20.2278     Document Type: Article

References (44)

1. Melton LJ III, Kan SH, Frye MA, Wahner HW, O'Fallon WM, Riggs BL. Epidemiology of vertebral fractures in women. Am J Epidemiol 1989;129:1000-1011.
2. Barrett JA, Baron JA, Karagas MR, Beach ML, Fracture risk in the US Medicare population. J Clin Epidemiol. 1999;52:243-249.
3. Ray NF, Chan JK, Thamer M, et al. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation. J Bone Miner Res. 1997;12:24-35.
4. Wells G, Tugwell P, Shea B, et al, for the Osteoporosis Methodology Group and the Osteoporosis Research Advisory Group. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev. 2002;23:529-539.
5. Kiel DP, Felson DT, Anderson JJ, Wilson PW, Moskowitz MA. Hip fracture and the use of estrogens in postmenopausal women: The Framingham Study. N Engl J Med. 1987;317:1169-1174.
6. Naessen T, Persson I, Adami HO, Bergstrom R, Bergkvist L. Hormone replacement therapy and the risk for first hip fracture: A prospective, population-based cohort study. Ann Intern Med. 1990;113:95-103.
7. Grodstein F, Stampfer MJ, Falkeborn M, Naessen T, Persson I. Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women. Epidemiology. 1999;10:476-480.
8. Maxim P, Ettinger B, Spitalny GM. Fracture protection provided by long-term estrogen treatment. Osteoporosis Int. 1995;5:23-29.
9. Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR. Estrogen replacement therapy and fractures in older women. Ann Intern Med. 1995;122:9-16.
10. Torgerson D, Bell-Syer S. Hormone replacement therapy and prevention of nonvertebral fractures: A meta-analysis of randomized trials. JAMA. 2001;285:2891-2897.
11. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 2002;288:321-333.
12. Komulainen MH, Kroger H, Tuppurainen MT, et al. HRT and vit D in prevention of non-vertebral fractures in postmenopausal women: A 5 year randomized trial. Maturitas. 1998;31:45-54.
13. Lufkin EG, Wahner HW, O'Fallon WM, et al. Treatment of postmenopausal os-teoporosis with transdermal estrogen. Ann Intern Med. 1992;117:1-9.
14. Wimalawansa SJ. A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis. Am J Med. 1998;104:219-226.
15. Hulley S, Grady D, Bush T, et al, for the Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 1998;280:605-613.
16. Cauley JA, Black D, Barrett-Connor E, et al. Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/progestin Replacement Study (HERS). Am J Med. 2001;110:442-450.
17. Hulley S, Furberg C, Barrett-Connor E, et al. Noncardiovascular disease outcomes during 8.6 years of hormone therapy. JAMA. 2002;288:58-66.
18. Ensrud KE, Palermo L, Black DM, et al. Hip and calcaneal bone loss increase with advancing age: Longitudinal results from the Study of Osteoporotic Fractures. J Bone Miner Res. 1995;10:1778-1787.
19. Cummings SR, Black DM, Nevitt MC, et al, for the Study of Osteoporotic Fractures Research Group. Appendicular bone density and age predict hip fracture in women. JAMA. 1990;263:665-668.
20. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. N Engl J Med. 1995;332:767-773.
21. Cummings SR, Block G, McHenry K, Baron RB. Evaluation of two food frequency methods of measuring dietary calcium intake. Am J Epidemiol. 1987;126:796-802.
22. Paffenbarger RS Jr, Wing AL, Hyde RT. Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol. 1978;108:161-175.
23. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) Examination. J Clin Psychiatry. 1987;48:314-318.
24. Steiger P, Cummings SR, Black DM, Spencer NE, Genant HK. Age-related decrements in bone mineral density in women over 65. J Bone Miner Res. 1992;7:625-632.
25. Nevitt MC, Cummings SR, Browner WS, et al. The accuracy of self-report of fractures in elderly women: Evidence from a prospective study. Am J Epidemiol. 1992;135:490-499.
26. Nevitt MC, Ettinger B, Black DM, et al. The association of radiographically detected vertebral fractures with back pain and function: A prospective study. Ann Intern Med. 1998;128:793-800.
27. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report. Osteoporos Int. 1994;4:368-381.
28. Bauer DC, Browner WS, Cauley JA, et al. Factors associated with appendicular bone mass in older women. Ann Intern Med. 1993;118:657-665.
29. Eiken P, Kolthoff N, Nielsen SP. Effect of 10 years' hormone replacement therapy on bone mineral content in postmenopausal women. Bone. 1996;19:191S-193S.
30. Christiansen C, Christiansen M, Transbol I. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet. 1981;1:459-461.
31. Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 1985;102:319-324.
32. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1016-1037.
33. Lindsay R, Tohme JF. Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynecol. 1990;76:290-295.
34. Prince RL, Smith M, Dick IM, et al. Prevention of postmenopausal osteoporosis: A comparative study of exercise, calcium supplementation, and hormone replacement therapy. N Engl J Med. 1991;325:1189-1195.
35. Beck TJ, Stone KL, Oreskovic TL, et al. Effects of current and discontinued estrogen replacement therapy on hip structural geometry: The Study of Osteoporotic Fractures. J Bone Miner Res. 2001;16:2103-2110.
36. Cauley JA, Zmuda JM, Ensrud KE, Bauer DC, Ettinger B. Timing of estrogen replacement therapy for optimal osteoporosis prevention. J Clin Endocrinol Metab. 2001;86:5700-5705.
37. Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med. 1991;115:455-456.
38. Cauley JA, Seeley DG, Browner WS, et al. Estrogen replacement therapy and mortality among older women: The Study of Osteoporotic Fractures. Arch Intern Med. 1997;157:2181-2187.
39. Keating N, Cleary P, Rossi A, Zaslavsky A, Ayanian J. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med. 1999;130:545-553.
40. Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prior use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol. 1996;143:971-978.
41. Folsom AR, Mink PJ, Sellers TA, Hong CP, Zheng W, Potter JD. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health. 1995;85:1128-1132.
42. American Association of Clinical Endocrinologists. AACE clinical practice guidelines for the prevention and treatment of postmenopausal osteoporosis. J Fla Med Assoc. 1996;83:552-566.
43. National Osteoporosis Foundation. Osteoporosis: Review of the Evidence for Prevention, Diagnosis, and Treatment and Cost-Effectiveness Analysis. Washington, DC: National Osteoporosis Foundation; 1998.
44. Cauley JA, Cummings SR, Black DM, Mascioli SR, Seeley DG. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 1990;163:1438-1444.